Get the Stockscreener App
7.56
0.00%
0.00
After Hours:
7.58
0.02
+0.26%
Absci Corp stock is traded at $7.56, with a volume of 2.45M.
It is up +0.00% in the last 24 hours and down -30.58% over the past month.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
See More
Previous Close:
$7.56
Open:
$7.805
24h Volume:
2.45M
Relative Volume:
0.43
Market Cap:
$1.28B
Revenue:
$1.84M
Net Income/Loss:
$-118.44M
P/E Ratio:
-9.1183
EPS:
-0.8291
Net Cash Flow:
$-98.51M
1W Performance:
-7.35%
1M Performance:
-30.58%
6M Performance:
+153.69%
1Y Performance:
+161.59%
1-Day Range:
$7.55
$8.09
1-Week Range:
$7.51
$8.47
52-Week Range:
$2.24
$12.05
Absci Corp Stock (ABSI) Company Profile
Name
Absci Corp
Sector
Industry
Phone
(360) 949-1041
Address
18105 SE MILL PLAIN BLVD, VANCOUVER
Compare ABSI vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
7.56 | 1.28B | 1.84M | -118.44M | -98.51M | -0.8291 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-26 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-02-25 | Initiated | JP Morgan | Overweight |
| Jul-03-25 | Resumed | Morgan Stanley | Overweight |
| Jan-22-25 | Initiated | Needham | Buy |
| Oct-02-24 | Initiated | Guggenheim | Buy |
| Jul-03-24 | Initiated | Morgan Stanley | Overweight |
| Mar-14-24 | Initiated | Scotiabank | Sector Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-04-23 | Initiated | H.C. Wainwright | Buy |
| Aug-12-22 | Downgrade | JP Morgan | Overweight → Underweight |
| Jul-18-22 | Initiated | Truist | Buy |
| Mar-02-22 | Resumed | Cowen | Market Perform |
| Feb-01-22 | Initiated | Berenberg | Buy |
| Nov-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Aug-16-21 | Initiated | BofA Securities | Neutral |
| Aug-16-21 | Initiated | Cowen | Market Perform |
| Aug-16-21 | Initiated | Credit Suisse | Outperform |
| Aug-16-21 | Initiated | Stifel | Hold |
View All
Absci Corp Stock (ABSI) Latest News
A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed - marketscreener.com
ABSI|Absci Corp|Price:7.565|Chg%:+0.005 - TradingKey
Absci Corp (ABSI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Absci Corp (ABSI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
ABSI|Absci Corp|Price:7.726|Chg%:+0.167 - TradingKey
Absci Corp (ABSI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ABSI|Absci Corp|Price:7.560|Chg%:-0.510 - TradingKey
Absci Corporation (ABSI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Absci Corporation (ABSI) Options Chain - Yahoo! Finance Canada
ABSI Stock Eyes Best Day Ever After Positive Hair Loss Drug Data, $100M Lilly-Backed Raise - Stocktwits
Siren L.L.C. Takes $5.40 Million Position in Absci Corporation $ABSI - MarketBeat
Absci Corp (ABSI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASD - The National Law Review
Wall Street analysts predict a 28.3% upside in ABSCI Corp (ABSI): Here's what you should know - MSN
Absci to report Q2FY26 results on August 11, 2026 - scanx.trade
Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026 - GlobeNewswire
Wall Street Analysts Predict a 28.3% Upside in ABSCI CORP (ABSI): Here's What You Should Know - Yahoo Finance
Wall Street Zen Downgrades Absci (NASDAQ:ABSI) to Sell - MarketBeat
Pre-Market Movement | Absci's Put/Call Ratio Rises - 富途牛牛
Absci director Mary T Szela buys $148,866 in stock - Investing.com
Absci director Mary T Szela buys $148,866 in stock By Investing.com - Investing.com Nigeria
H.C. Wainwright Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $16 - 富途牛牛
Form 4 Absci Corp For: 6 July By Investing.com - Investing.com Nigeria
Absci (ABSI) director buys 12,900 shares in open-market trade - Stock Titan
ABSCI CORP (ABSI) soars 36.0%: Is further upside left in the stock? - MSN
ABSI Maintained by Truist Securities -- Price Target Raised to $17.00 - GuruFocus
Truist Financial Maintains Absci Corp(ABSI.US) With Buy Rating, Raises Target Price to $17 - 富途牛牛
Here's Why Absci Corporation (ABSI) is a Great Momentum Stock to Buy - Yahoo Finance
BTIG Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $13 - 富途牛牛
Price to book forward of Absci Corporation – NASDAQ:ABSI - TradingView
AbSci2026 Funding Rounds & List of Investors - Tracxn
Absci Stock (ABSI) Opinions on Positive Phase 1 Data for ABS-201 - Moomoo
Absci Raises $100 Million In Equity To Fund AI-Designed Hair Loss And Endometriosis Program - Yahoo Finance
Absci (NASDAQ:ABSI) Rating Increased to Hold at Wall Street Zen - MarketBeat
Form 4 Absci Corp For: 26 June By Investing.com - Investing.com Australia
Absci (NASDAQ: ABSI) CEO has 59,896 shares withheld for RSU tax obligation - Stock Titan
Absci (ABSI) Is Up 37.8% After ABS-201 Data And Equity RaiseHas The Bull Case Changed? - Yahoo Finance
Absci Corporation (NASDAQ:ABSI) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Absci Corp Stock (ABSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.97%
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):